193 related articles for article (PubMed ID: 21572317)
21. Cyclopropyl-methoxycarbonyl Metomidate: Studies in a Lipopolysaccharide Inflammatory Model of Sepsis.
Santer P; Pejo E; Feng Y; Chao W; Raines DE
Anesthesiology; 2015 Aug; 123(2):368-76. PubMed ID: 26035348
[TBL] [Abstract][Full Text] [Related]
22. Modifying methoxycarbonyl etomidate inter-ester spacer optimizes in vitro metabolic stability and in vivo hypnotic potency and duration of action.
Husain SS; Pejo E; Ge R; Raines DE
Anesthesiology; 2012 Nov; 117(5):1027-36. PubMed ID: 22929736
[TBL] [Abstract][Full Text] [Related]
23. New insights for screening etomidate analogues in the human H295R cell model.
Deng C; Gong D; Yang J; Ke B; Kang Y; Liu J; Zhang W
Toxicol In Vitro; 2020 Oct; 68():104934. PubMed ID: 32653408
[TBL] [Abstract][Full Text] [Related]
24. E161111 is an ultra-short-acting etomidate analogue with stable haemodynamics that elicits only slight adrenocortical suppression in rats.
Wang B; Gong D; Kang Y; Liu J; Yang J; Zhang WS
PeerJ; 2022; 10():e13492. PubMed ID: 35646481
[TBL] [Abstract][Full Text] [Related]
25. Minimum infusion rate and adrenocortical function after continuous infusion of the novel etomidate analog ET-26-HCl in rats.
Jiang J; Wang B; Zhu Z; Yang J; Liu J; Zhang W
PeerJ; 2017; 5():e3693. PubMed ID: 28890850
[TBL] [Abstract][Full Text] [Related]
26. A Phase 1, Single-center, Double-blind, Placebo-controlled Study in Healthy Subjects to Assess the Safety, Tolerability, Clinical Effects, and Pharmacokinetics-Pharmacodynamics of Intravenous Cyclopropyl-methoxycarbonylmetomidate (ABP-700) after a Single Ascending Bolus Dose.
Struys MMRF; Valk BI; Eleveld DJ; Absalom AR; Meyer P; Meier S; den Daas I; Chou T; van Amsterdam K; Campagna JA; Sweeney SP
Anesthesiology; 2017 Jul; 127(1):20-35. PubMed ID: 28459733
[TBL] [Abstract][Full Text] [Related]
27. Etomidate derivatives: Novel pharmaceutical agents in anesthesia.
Malapero RJ; Zaccagnino MP; Brovman EY; Kaye AD; Urman RD
J Anaesthesiol Clin Pharmacol; 2017; 33(4):429-431. PubMed ID: 29416230
[TBL] [Abstract][Full Text] [Related]
28. Carboetomidate inhibits alpha4/beta2 neuronal nicotinic acetylcholine receptors at concentrations affecting animals.
Pierce DW; Pejo E; Raines DE; Forman SA
Anesth Analg; 2012 Jul; 115(1):70-2. PubMed ID: 22543065
[TBL] [Abstract][Full Text] [Related]
29. I.v. anaesthesia and EEG burst suppression in rats: bolus injections and closed-loop infusions.
Vijn PC; Sneyd JR
Br J Anaesth; 1998 Sep; 81(3):415-21. PubMed ID: 9861133
[TBL] [Abstract][Full Text] [Related]
30. Carboetomidate: will it eliminate the etomidate debate?
Jackson WL
Crit Care Med; 2012 Jan; 40(1):333-4. PubMed ID: 22179369
[No Abstract] [Full Text] [Related]
31. Dimethoxy-etomidate: A Nonhypnotic Etomidate Analog that Potently Inhibits Steroidogenesis.
McGrath M; Ma C; Raines DE
J Pharmacol Exp Ther; 2018 Feb; 364(2):229-237. PubMed ID: 29203576
[TBL] [Abstract][Full Text] [Related]
32. Novel etomidate derivatives.
Sneyd JR
Curr Pharm Des; 2012; 18(38):6253-6. PubMed ID: 22762475
[TBL] [Abstract][Full Text] [Related]
33. Metabolite-inactive etomidate analogues alleviating suppression on adrenal function in Beagle dogs.
Yang J; Kang Y; Wang B; Yang L; Liu J; Zhang W
Eur J Pharm Sci; 2017 Mar; 99():343-349. PubMed ID: 28057551
[TBL] [Abstract][Full Text] [Related]
34. γ-Aminobutyric Acid Type A Receptor Modulation by Etomidate Analogs.
Pejo E; Santer P; Wang L; Dershwitz P; Husain SS; Raines DE
Anesthesiology; 2016 Mar; 124(3):651-63. PubMed ID: 26691905
[TBL] [Abstract][Full Text] [Related]
35. Infusion strategies to investigate the pharmacokinetics and pharmacodynamics of hypnotic drugs: etomidate as an example.
Schüttler J; Schwilden H; Stoeckel H
Eur J Anaesthesiol; 1985 Jun; 2(2):133-42. PubMed ID: 4029127
[TBL] [Abstract][Full Text] [Related]
36. Profile of etomidate. A hypnotic, anticonvulsant and brain protective compound.
Wauquier A
Anaesthesia; 1983 Jul; 38 Suppl():26-33. PubMed ID: 6346937
[TBL] [Abstract][Full Text] [Related]
37. The preclinical pharmacological study of a novel intravenous anesthetic, ET-26 hydrochloride, in aged rats.
Chang P; Su Y; Gong D; Kang Y; Liu J; Zhang Y; Zhang WS
PeerJ; 2022; 10():e13995. PubMed ID: 36196398
[TBL] [Abstract][Full Text] [Related]
38. Etomidate suppresses adrenocortical function by inhibition of 11 beta-hydroxylation.
de Jong FH; Mallios C; Jansen C; Scheck PA; Lamberts SW
J Clin Endocrinol Metab; 1984 Dec; 59(6):1143-7. PubMed ID: 6092411
[TBL] [Abstract][Full Text] [Related]
39. Effects of dexmedetomidine, a novel imidazole sedative-anesthetic agent, on adrenal steroidogenesis: in vivo and in vitro studies.
Maze M; Virtanen R; Daunt D; Banks SJ; Stover EP; Feldman D
Anesth Analg; 1991 Aug; 73(2):204-8. PubMed ID: 1649559
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of adrenal steroidogenesis by the anesthetic etomidate.
Wagner RL; White PF; Kan PB; Rosenthal MH; Feldman D
N Engl J Med; 1984 May; 310(22):1415-21. PubMed ID: 6325910
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
